BioCentury | Sep 29, 2008
Product Development

Ophthalmic deals

...Jun 08 Opko (AMEX:OPK)/Redox Undisclosed Opko acquires exclusive worldwide rights to develop and commercialize Doxovir (CTC-96...
BioCentury | Jun 16, 2008
Company News

Opko, Redox Pharmaceutical Corp. deal

...Opko acquired exclusive, worldwide rights from Redox to develop and commercialize Doxovir ( CTC-96 ) for...
BioCentury | Jun 14, 1999
Company News

Redox Pharmaceutical Corp., Trima Pharmaceutical Products Maarbarot Ltd. deal

...The companies will evaluate the development of a product combining Redox’s Doxovir CTC-96 metallo-organic compound with...
...drug delivery vehicle to treat wounds. The companies also will collaborate on a formulation of Doxovir...
BioCentury | Jun 1, 1999
Company News

Redox Pharmaceutical Corp. other research news

...to develop its Doxovir to prevent genital herpes. Redox Pharmaceutical Corp., Southampton, N.Y. Product: Doxovir CTC-96...
Items per page:
1 - 4 of 4